hiv aids

Low-cost preventative HIV medication may be ready as early as 2026, as British pharmaceutical company GSK strikes a deal allowing developing countries access to generic versions.

The woman has shown no detectable signs of the human immunodeficiency virus in extensive testing since she stopped antiretroviral treatment in October 2020 following a transplant of stem cells with a rare genetic mutation that blocks HIV invasion, her doctors said.

A South African girl born with the AIDS virus has kept her infection suppressed for more than eight years after stopping anti-HIV medicines.